- Home
- CURI vs ADAG Comparison
CURI vs ADAG Comparison
Compare CURI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- ADAG
- Stock Information
- Founded
- CURI 2015
- ADAG 2011
- Country
- CURI United States
- ADAG China
- Employees
- CURI N/A
- ADAG N/A
- Industry
- CURI Movies/Entertainment
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- ADAG Health Care
- Exchange
- CURI Nasdaq
- ADAG Nasdaq
- Market Cap
- CURI 101.0M
- ADAG 85.9M
- IPO Year
- CURI N/A
- ADAG 2021
- Fundamental
- Price
- CURI $2.09
- ADAG $1.77
- Analyst Decision
- CURI Strong Buy
- ADAG Strong Buy
- Analyst Count
- CURI 1
- ADAG 1
- Target Price
- CURI $3.00
- ADAG $5.00
- AVG Volume (30 Days)
- CURI 276.3K
- ADAG 24.0K
- Earning Date
- CURI 03-19-2025
- ADAG 03-09-2025
- Dividend Yield
- CURI 4.83%
- ADAG N/A
- EPS Growth
- CURI N/A
- ADAG N/A
- EPS
- CURI N/A
- ADAG N/A
- Revenue
- CURI $51,775,000.00
- ADAG $815,746.00
- Revenue This Year
- CURI N/A
- ADAG N/A
- Revenue Next Year
- CURI $9.18
- ADAG $2.70
- P/E Ratio
- CURI N/A
- ADAG N/A
- Revenue Growth
- CURI N/A
- ADAG N/A
- 52 Week Low
- CURI $0.45
- ADAG $1.74
- 52 Week High
- CURI $3.00
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- CURI 68.14
- ADAG 37.29
- Support Level
- CURI $1.53
- ADAG $1.76
- Resistance Level
- CURI $2.17
- ADAG $1.89
- Average True Range (ATR)
- CURI 0.15
- ADAG 0.13
- MACD
- CURI 0.07
- ADAG -0.00
- Stochastic Oscillator
- CURI 88.41
- ADAG 3.53
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.